From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.
Chromosome rearrangements associated with neoplasms provide a rich resource for definition of the pathways of tumorigenesis. The power of comparative genome hybridization (CGH) to identify novel genes depends on the existence of suitable markers, which are lacking throughout most of the genome. We now report a general approach that translates CGH data into higher-resolution genomic-clone data that are then used to define the genes located in aneuploid regions. We used CGH to study 33 thyroid-tumor DNAs and two tumor-cell-line DNAs. The results revealed amplifications of chromosome band 2p21, with less-intense amplification on 2p13, 19q13.1, and 1p36 and with least-intense amplification on 1p34, 1q42, 5q31, 5q33-34, 9q32-34, and 14q32. To define the 2p21 region amplified, a dense array of 373 FISH-mapped chromosome 2 bacterial artificial chromosomes (BACs) was constructed, and 87 of these were hybridized to a tumor-cell line. Four BACs carried genomic DNA that was amplified in these cells. The maximum amplified region was narrowed to 3-6 Mb by multicolor FISH with the flanking BACs, and the minimum amplicon size was defined by a contig of 420 kb. Sequence analysis of the amplified BAC 1D9 revealed a fragment of the gene, encoding protein kinase C epsilon (PKCepsilon), that was then shown to be amplified and rearranged in tumor cells. In summary, CGH combined with a dense mapped resource of BACs and large-scale sequencing has led directly to the definition of PKCepsilon as a previously unmapped candidate gene involved in thyroid tumorigenesis.
Ahmanson Department of Pediatrics, Division of Genetics, Cedars-Sinai Research Institute, UCLA School of Medicine, Los Angeles, USA.
X
X
Chen
J A
JA
Knauf
R
R
Gonsky
M
M
Wang
E H
EH
Lai
S
S
Chissoe
J A
JA
Fagin
J R
JR
Korenberg
D018263:Adenocarcinoma, Follicular / Q000235:genetics; D000236:Adenoma / Q000235:genetics; D002277:Carcinoma / Q000235:genetics; D002291:Carcinoma, Papillary / Q000235:genetics; D002869:Chromosome Aberrations; D002874:Chromosome Mapping; D002876:Chromosomes, Bacterial; D002877:Chromosomes, Human; D002878:Chromosomes, Human, Pair 1; D002889:Chromosomes, Human, Pair 2; D004273:DNA, Neoplasm / Q000235:genetics; D005784:Gene Amplification; D005819:Genetic Markers; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D013964:Thyroid Neoplasms / Q000235:genetics*; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D005819:Genetic Markers